Current Liabilities 更改
AbbVie USD 41.52B 6.75B 2024-03
Agios Pharmaceuticals USD 51.69M 16.26M 2024-03
Alnylam Pharmaceuticals USD 941.71M 26.08M 2024-03
Amgen USD 19.71B 1.32B 2024-03
Arrowhead Research USD 65.18M 1.45M 2024-03
Astellas Pharma JPY 1.15T 8.54B 2023-12
AstraZeneca USD 28.9B 1.64B 2024-03
Bayer EUR 30.63B 1.17B 2024-03
Biogen USD 3.22B 211.5M 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Daiichi Sankyo JPY 606.81B 74.56B 2023-12
Eli Lilly USD 18.6B 3.4B 2024-03
Exelixis USD 373.01M 3.81M 2024-03
Gilead Sciences USD 13.02B 1.74B 2024-03
GlaxoSmithKline GBP 19.85B 1.22B 2024-03
Incyte USD 1.4B 156.07M 2024-03
Ionis Pharmaceuticals USD 327.65M 120.44M 2024-03
Merck USD 25.1B 2.01B 2024-03
Moderna USD 2.38B 635M 2024-03
Novartis USD 29.29B 2.9B 2024-03
Novartis USD 29.29B 2.9B 2024-03
Pfizer USD 40.5B 9.36B 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Roche Holding CHF 24.82B 1.38B 2023-12
Sarepta Therapeutics USD 608.71M 157.97M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03



Agios Pharmaceuticals 流动负债 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.